Le Lézard
Classified in: Health
Subjects: FDA, MAT

DBM Corporation Inc., Announces FDA 510(k) Market Clearance for MIRACU PDO Threads in U.S Market


MISSION VIEJO, Calif., Dec. 11, 2018 /PRNewswire/ -- DBM Corporation, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for MIRACU PDO Threads, a huge accomplishment for the company, as it marks the first PDO thread  to receive 510 (k) clearance in the U.S. market. DBM Corporation Inc., the official US representative of MIRACU PDO Threads, will be adding this product listing to the top of their ever growing exclusive medical portfolio.

DBM Corporation Inc. is the Official US Distributor of MIRACU PDO Threads

MIRACU PDO Threads have redefined predated sutures, with its innovative cannula and thread technology. The threads are defined as a medical device, with indications for use on soft approximation where absorbable sutures are appropriate. The devices cannula (needle) has a surface coating smoother than that of traditional catgut sutures, coupled with ultra-thin walls for maximum pain relief.  The threads are designed to remain in the body up 240 days, and thereafter are converted into water and carbon dioxide, and are fully absorbed without any residue, through a process known as hydrolysis. MIRACU PDO Threads are available in a variety of cannula types including but not limited to FC, FC45, FCL, and FCN, in addition to a bevy of PDO Thread types including but not limited to Mono, Screw, Cog and Forte.

"We are excited to offer medical professionals MIRACU PDO Threads," said Ethan Min, CEO of DBM Corporation Inc. "MIRACU PDO Threads have redefined sutures, with its safety and effectiveness providing results, at an affordable cost,  and will deliver considerable value to surgeons, patients, and hospitals alike."

Medical professionals have been making waves since news of MIRACU PDO Threads class two approval. The medical community has long awaited a class two backing for PDO threads, but none thus far had succeeded. To now have MIRACU PDO Threads, as the global front runner for PDO threads on the market, due to their technological advances, and also receive the first US backing, will allow for treatments to be conducted with the highest amount of confidence, in regards to both safety and effectiveness.

The buzz in the medical community ...

"My business is geared towards aesthetics. As a medical professional, I look for products that offer more for my patients, products that don't sacrifice safety or effectiveness. Since integrating MIRACU PDO Threads into my list of services and procedures, my business has grown considerably, as many patients opt for non invasive solutions, that offer immediate results." - Dr. Schreiber

"The US FDA providing a 510(k) backing for MIRACU PDO Threads provided me with the assurance in the product that I needed to integrate MIRACU PDO Threads into my practice.  My clinic offers now a bevy of treatments that are geared towards patients that want a lunchtime treatment, or a more in-depth transformation." - Dr. Jin

MIRACU PDO Threads show no sign of slowing down. With more and more patients requesting treatments with the innovative threads, we expect in 2019 that over 58% of Medical Practitioners will be integrating PDO Threads into their practice, with 78% by 2020, and 91% by 2021.

To ensure safety, and effectiveness for your patients, we urge that all sales of MIRACU PDO Threads be made through an authorized distributor. For best treatments results we highly recommend enrollment in an authorized MIRACU PDO Thread Seminar.

About DBM Corporation Inc. DBM Corporation, Inc., headquartered in Mission Viejo, California, is a solution provider for medical aesthetic needs in U.S. market. DBM Corporation is the Official North America Representative of MIRACU PDO Threads.

For More Information Regarding MIRACU PDO Threads, To Place An Order,  Or Attend One Of Our Educational Seminars, Please Contact DBM Corporation Inc at 1-949-329-8124, or visit www.MIRACUUSA.com

About Apollo Med Innovations, LLC. 
Apollo Med Innovations, LLC is a leading distributor of cutting edge aesthetic products to the MedSpa and aesthetic industries. Apollo Med Innovations, LLC. is the Official Distributor of MIRACU, PDO Threads in all territories East of the Mississippi, in addition to the state of Texas.

For More Information Regarding MIRACU PDO Threads, To Place An Order,  Or Attend One Of Apollo Med Innovations LLC Educational Seminars, Please Contact Apollo Med Innovations, LLC. at 1- 888-473-9066, or visit www.ApolloMedInnovations.com

**Any forward-looking statements are subject to risks and uncertainties such as those described in DBM Corporation's periodic reports. Actual results may differ materially from anticipated results.**

 

SOURCE DBM Corporation, Inc.


These press releases may also interest you

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...



News published on and distributed by: